4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-26-000060
CEO acquired 250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schuetz Thomas J. CEO | 2026-01-02 | Grant or award | +250,000 | $5.17 | $1,292,500 | 6,686,800 | D |
| Derivatives | |||||||
| Schuetz Thomas J. CEO | 2026-01-02 | Grant or award · Stock Option (Right to Buy) | +2,000,000 | 2,000,000 | D | ||
Loading xslF345X05/ownership.xml…